Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ventricular Catheter Flushing System Restores CSF Flow

By HospiMedica International staff writers
Posted on 06 Jun 2018
A non-invasive retrograde flushing system helps clinicians restore or increase cerebrospinal fluid (CSF) flow in a blocked ventricular catheter shunt.

The Anuncia (Lowell, MA, USA) Alivio System is designed to provide a non-invasive option for neurosurgeons to restore CSF flow in a non-flowing shunt, which may potentially avert emergency revision surgery. More...
The system, which can be used in conjunction with any CSF shunt flow-regulating valve and drainage catheter, is comprised of a flusher and a ventricular catheter (VC) with a unique relief membrane that restores or increase CSF flow in a and unblocks occluded inlet holes.

The flusher component does not regulate CSF flow in the implanted shunt system; instead, it allows fluid from the ventricular catheter to flows freely, without restriction through a passive flow channel. During flushing, the passive channel is manually occluded to create temporary one-way flow into the VC. After a controlled and limited fluid pulse is sent from the flusher, the flush dome refills with CSF from the VC and resumes free flowing fluid through the passive flow channel.

In the case of completely obstructed flow through the shunt, retrograde flushing of the VC is performed by depression of the flush dome, which sends a controlled and limited pulse of fluid--either native CSF or sterile saline introduced during a priming procedure before implant--into the VC. In a life-threatening case of a severely occluded catheter, the relief membrane of the VC opens to restore antigrade flow in the shunt system.

“If you have a shunt, you are always worried about what might happen in the future. Close to half of shunts will have a revision within the first year of implantation. About 80% will require a revision within 10 years,” said neurosurgeon Joseph Madsen, MD, co-inventor of the Alivio system. “I am delighted that my fellow neurosurgeons will have an option to intervene non-invasively when treating hydrocephalus patients who come in with complications related to ventricular shunt obstruction.”

Hydrocephalus is a condition in which an excess of CSF accumulates within the ventricles and increases pressure in the brain. But even as implanted CSF shunts help relieve the pressure build-up, according to the Hydrocephalus Association (Bethesda, MD, USA), at least 50% of patients suffer from shunt failures and blockages within two years, requiring repeated revision surgeries. The costs of these often-emergent, revision surgeries to restore CSF flow and alleviate painful symptoms present a heavy emotional and financial burden to patients, families, and healthcare facilities.

Related Links:
Anuncia
Hydrocephalus Association


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.